Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Size, Share Report 2032

Novel Drug Delivery Systems (NDDS) In Cancer Therapy Market: Industry Perspective

The global novel drug delivery systems (NDDS) in cancer therapy market size was worth around USD 15.46 Billion in 2023 and is predicted to grow to around USD 80.95 Billion by 2032 with a compound annual growth rate (CAGR) of roughly 20.2% between 2024 and 2032. The report analyzes the global novel drug delivery systems (NDDS) in cancer therapy market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the novel drug delivery systems (NDDS) in cancer therapy industry.

Request Free Sample

In order to give the users of this report a comprehensive view on the novel drug delivery systems (NDDS) in cancer therapy market we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

Request Free Sample

The report provides company market share analysis in order to give a broader overview of the key players in the novel drug delivery systems (NDDS) in cancer therapy market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new type launches, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the novel drug delivery systems (NDDS) in cancer therapy market on a global and regional basis.

Novel Drug Delivery Systems (NDDS) In Cancer Therapy Market: Overview

A novel drug delivery system (NDDS) aims to deliver medication in a manner that increases its concentration at a specific site relative to other parts of the body. NDSS typically involves the use of nanoparticles and embolization particles. The drug is encapsulated inside the particles, which protects the drug from enzymatic and chemical degradation inside the cellular environment when administered into the body. NDSS is focused on reducing dose administration frequency, uniform drug release profile, minimizing side effects, and reducing fluctuating levels of circulating drugs.

Novel Drug Delivery Systems (NDDS) In Cancer Therapy Market: Dynamics

The demand for novel drug delivery systems (NDDS) in cancer therapy market is driven by a growing preference for novel and efficient drug delivery systems with minimal adverse events, increasing cancer awareness and prevalence across the globe. Additionally, increasing healthcare spending, increasing R&D investment by major manufacturers for novel therapy development, and ongoing new drug approvals from regulatory authorities are important factors that boost market growth.

However, the high cost of therapy may limit the market growth over the forecast period. Untapped markets are projected to bring growth opportunities over the forecast period for major key players in novel drug delivery systems (NDDS) in cancer therapy market.

Novel Drug Delivery Systems (NDDS) In Cancer Therapy Market: Segmentation Analysis

The study provides a crucial view of the novel drug delivery systems (NDDS) in cancer therapy by segmenting the market based on type and region. All the segments of novel drug delivery systems (NDDS) in cancer therapy market have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on type, the global novel drug delivery systems (NDDS) in cancer therapy market are segmented into embolization particles and nanoparticles. The nanoparticles type segment accounted for the largest market share in 2023 due to their efficiency. The nanoparticles type segment is sub segmented into micelles, polymers, liposomes and other nanoparticles. The embolization particles segment is sub-segmented into drug-eluting beads, liquid emboli, PVA particles and other embolization particles. Nanoparticles encapsulate the drugs and thus the drug can be protected from enzymatic and chemical degradation when administered. Also, nanoparticles have a longer half-life and thus can improve the pharmacokinetics profile with longer circulation time along with lesser side effects and enhanced permeability. Due to these advantages, nanoparticles are of preferred choice for novel drug delivery system in cancer therapy.

Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Report Scope

Novel Drug Delivery Systems (NDDS) In Cancer Therapy Market: Regional Analysis

North America dominated the global novel drug delivery systems (NDDS) in cancer therapy market in 2023. Increasing cancer prevalence, surge in number of research projects for new therapies, presence of developed R&D infrastructure, increasing R&D spending and increasing awareness about therapies with minimal side effects due to increasing promotional activities by manufacturers and favorable reimbursement policies are factors driving the market in this region. Europe was the second largest regional novel drug delivery systems (NDDS) in cancer therapy market. Growing awareness about advanced cancer therapies with minimal side effects, swift adoption of novel therapies and favorable reimbursement policies for cancer are major factors that boost market growth in this region. Latin America is projected to exhibit moderate growth over the forecast period.

Asia Pacific region will register the highest CAGR for novel drug delivery systems (NDDS) in cancer therapy market during the forecast period. Increasing cancer prevalence, growing awareness about novel therapies and increasing healthcare spending are factors promoting novel drug delivery systems (NDDS) in cancer therapy market growth in Asia Pacific. The Middle East and Africa region is estimated to show slower growth in coming years.

Novel Drug Delivery Systems (NDDS) In Cancer Therapy Market: Competitive Analysis

Some of the major players in the global novel drug delivery systems (NDDS) in cancer therapy market include:

• BTG
• Spectrum Pharmaceuticals, Inc.
• Celgene Corporation
• Samyang Biopharmaceuticals Corporation
• Shire
• Merrimack Pharmaceuticals, Inc.
• GALEN
• Johnson & Johnson Services, Inc.
• Teva Pharmaceutical Industries Ltd.

The global novel drug delivery systems (NDDS) in cancer therapy market is segmented as follows;

Global Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: By Type

• Embolization Particles
  • PVA Particles
  • Drug Eluting Beads
  • Liquid Emboli
  • Other Embolization Particles
• Nanoparticles
  • Liposomes
  • Polymers
  • Micelles
  • Other nanoparticles

Global Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: By Region

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa